The Firm develops bioinformatics- and ML-based approaches to analysis of large diverse data sets, identifying epigenetic signatures of health and disease. This project is the development of ML-based approach for predicting the best treatment option for inflammatory conditions and cancer.
This record is a historical disbursement from Canada's open grants database — it documents a past payment, not an active program accepting applications.
View disbursement record →